http://www.neurology.org/content/83/14/1271
- Kristine S. Alexander, PhD, MCR,
- Neil A. Zakai, MD, MSc,
- Sarah Gillett, PhD,
- Leslie A. McClure, PhD,
- Virginia Wadley, PhD,
- Fred Unverzagt, PhD and
- Mary Cushman, MD, MSc
- Correspondence to Dr. Cushman: mary.cushman@uvm.edu
-
September 30, 2014 vol. 83 no. 14 1271-1276Neurology
- Abstract
- Full Text
- Full Text (PDF)
Abstract
Objective: To assess the relationships among ABO group, factor VIII (FVIII), and incident cognitive impairment in a large, prospective
cohort study of black and white adults in the United States using a nested case-control design.
Methods: Incident
cognitive impairment was defined using cognitive domain tests over a
mean follow-up of 3.4 years. ABO blood group
was measured by genotyping in a nested
case-control sample of 495 cases with cognitive impairment and 587
controls.
Results: Those with
blood group AB and those with higher FVIII had an increased risk of
cognitive impairment, adjusting for age, race,
region, and sex (respective odds ratios 1.82,
95% confidence interval [CI] 1.15–2.90; and 1.24, 95% CI 1.10–1.38 for
40 IU/dL
higher FVIII). Mean FVIII was higher in those
with blood type AB (142 IU/dL; 95% CI 119–165) compared with O (104
IU/dL; 95%
CI 101–107), and FVIII mediated 18% of the
association between AB group and incident cognitive impairment (95% CI
for mediation
−30% to 68%).
Conclusions: Blood
group AB and higher FVIII were associated with increased incidence of
cognitive impairment in this prospective study.
The association of blood group AB with incident
cognitive impairment was not significantly mediated by FVIII levels.
No comments:
Post a Comment